Evaluation of the Disintegration Properties of Commercial Famotidine 20mg Orally Disintegrating Tablets Using a Simple New Test and Human Sensory Test
スポンサーリンク
概要
- 論文の詳細を見る
The purpose of this study was to demonstrate the usefulness and broad-applicability of a simple disintegration test method for orally disintegrating tablets (ODT). Eight types of commercial famotidine 20mg orally disintegrating tablets with different physical properties (formulation, manufacturing method, tablet weight, shape, diameter, thickness, etc.), were used. Disintegration times of these tablets were evaluated employing human sensory test, conventional disintegration test, and the new proposed disintegration test. The human sensory test was performed in 5 healthy volunteers. In the conventional disintegration test, the disintegration apparatus described in the Japanese Pharmacopeia (JP 1^<st>) was used. Our proposed new test which is characterized by a rotating shaft with a low weight (10, 15g) and rotation speed (10, 25, 50rpm) was evaluated using tablets with and without storage under severe conditions (60℃/75%RH for 1 week). The disintegration times of famotidine 20mg orally disintegrating tablets in human sensory test varied from 9 to 32s. In contrast, disintegration times in the conventional test were prolonged to over 300s. Disintegration times in the new proposed test were close to those in human sensory test. Especially, when the new test was conducted with 15 or 10g weight and 25rpm, the slope (human sensory test vs. new proposed test) was almost 1. We were able to demonstrate that the new proposed test was useful to estimate the actual human disintegration time.
- 公益社団法人日本薬学会の論文
- 2006-08-01
著者
-
Iwamoto Kiyoshi
Formulation Research Laboratories Kawashima Research Eisai Co. Ltd.
-
Nagira Shinsuke
Formulation Res. Laboratories Kawashima Res. Eisai Co. Ltd.
-
NARAZAKI Ryuichi
Formulation Research Laboratory, Kawashima, Eisai Co., Ltd.,
-
HARADA Tsutomu
Formulation Research Laboratories, Kawashima Research, Eisai Co., Ltd.
-
OHWAKI Takayuki
Formulation Research Laboratories, Kawashima Research, Eisai Co., Ltd.
-
AOKI Shigeru
Formulation Research Laboratories, Kawashima Research, Eisai Co., Ltd.
-
Iwamoto Kiyoshi
Formulation Res. Lab. Eisai Co. Ltd.
-
Nagira Shinsuke
Formulation Research Laboratories Kawashima Research Eisai Co. Ltd.
-
Ohwaki T
Formulation Research Laboratories Kawashima Research Eisai Co. Ltd.
-
Aoki Shigeru
Formulation Research Laboratories Kawashima Research Eisai Co. Ltd.
-
Narazaki R
Formulation Research Laboratories Kawashima Research Eisai Co. Ltd.
-
Narazaki Ryuichi
Formulation Research Laboratory Kawashima Eisai Co. Ltd.
-
Narazaki Ryuichi
Formulation Research Laboratories, Kawashima Research, Eisai Co., Ltd.
関連論文
- Formation of Spherical Micelles by the Novel Platelet Activating Factor Receptor Antagonist, E5880
- The Effect of the Lipid A Analog, E5531 on Fever Induced by Endotoxin from Escherichia coli
- Tabletting of Solid Dispersion Particles Consisting of Indomethacin and Porous Silica Particles
- Evaluation of the Disintegration Properties of Commercial Famotidine 20mg Orally Disintegrating Tablets Using a Simple New Test and Human Sensory Test
- A Novel Rapid Quantitative Analysis of Drug Migration on Tablets Using Laser Induced Breakdown Spectroscopy
- A New Method for Evaluating the Bitterness of Medicines in Development Using a Taste Sensor and a Disintegration Testing Apparatus
- A New Method for Disintegration Studies of Rapid Disintegrating Tablet